Impact of diagnostic workup location on time to treatment for patients with non-small cell lung cancer seen in the emergency department.

580 Background: Most non-small cell lung cancer (NSCLC) diagnoses begin in the emergency department (ED), despite ED diagnoses being associated with higher mortality compared with those made outside the ED. Patients with new NSCLC are often admitted from the ED for complications or to expedite workup, as earlier treatment correlates with better survival. However, hospital stays are resource-intensive and may not reduce time to treatment initiation (TTI). We compared characteristics and TTI for patients with an ED diagnosis of NSCLC who underwent inpatient versus outpatient workups. Methods: We identified 2007 patients at Kaiser Permanente Northern California, a large integrated health system, with new NSCLC diagnosed within 30 days of an ED visit from 1/1/2018 to 12/31/2021. We randomly sampled 600 for chart review and excluded patients who died within 30 days or lacked pathologic confirmation. Using Cox proportional hazards, we adjusted for age, sex, race, neighborhood deprivation, comorbidities, and stage to assess the impact of workup location on TTI for patients receiving cancer-directed treatment within 30 days. Results: Of 480 patients included, 286 (60%) underwent inpatient workups and 194 (40%) had outpatient workups. In unadjusted analyses, hospitalized patients were more likely to have stage IV disease (69% vs. 53%, p<0.001) and to receive treatment within 30 days (40% vs. 29%, p=0.005), but less likely to be treated at 1 year (74% vs. 85%, p=0.005). After adjustment, there was no difference in TTI between groups for all patients or patients with stage IV disease treated within 30 days. Conclusions: In our study, inpatient and outpatient workups for a new ED diagnosis of NSCLC resulted in similar adjusted TTI. These findings suggest that for patients who may receive early treatment and do not require hospitalization, outpatient NSCLC workup does not delay treatment initiation. Identifying patients suitable for outpatient workup could help preserve hospital resources without impeding timely treatment. Characteristics and outcomes by workup location after ED diagnosis of NSCLC. Univariate analysis Overall 1 n = 480 Hospital 1 n = 286 Outpatient 1 n = 194 p-value 2 Age, mean (SD) 71.6 (11.3) 71.2 (11.8) 72.2 (10.7) 0.2 Male sex 205 (43) 119 (42) 86 (44) 0.6 Neighborhood Deprivation Index (NPI): 4th quartile (most deprived) 115 (24) 67 (23) 48 (35) 0.7 Charlson Comorbidity Index (CCI) ≥5 137 (29) 90 (31) 47 (24) 0.09 Stage IV disease 299 (62) 196 (69) 103 (53) <0.001 Multivariate analysis Hazard Ratio 95% CI p-value 3 Any treatment at 30 days 0.90 0.72, 1.14 0.377 Any treatment at 30 days, stage IV only 0.89 0.66, 1.19 0.428 1 n (%), unless otherwise stated; 2 Chi-square test (categorical variables) or Wilcoxon rank-sum test (continuous variables), unadjusted; 3 Cox proportional hazard model comparing outpatient to hospital; adjusted for age, sex, race, NPI, CCI, and stage.

Authors

Institutions

Publication Details

Journal
JCO Oncology Practice
Published
2025-10-01
DOI
https://doi.org/10.1200/op.2025.21.10_suppl.580
Primary Topic
Lung Cancer Treatments and Mutations
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Impact of diagnostic workup location on time to treatment for patients with non-small cell lung cancer seen in the emergency department.

Mary E. Reed, Raymond Liu, Mike Zhou Yang, Lori C. Sakoda et al.
JCO Oncology Practice
Lung Cancer Treatments and Mutations
article

Impact of diagnostic workup location on time to treatment for patients with non-small cell lung cancer seen in the emergency department.

Mary E. Reed, Raymond Liu, Mike Zhou Yang, Lori C. Sakoda, David R. Vinson, Madeline Somers, Meera Vimala Ragavan, Alexander Dang, Cynthia Triplett, Tina Huang
article en

Abstract

580 Background: Most non-small cell lung cancer (NSCLC) diagnoses begin in the emergency department (ED), despite ED diagnoses being associated with higher mortality compared with those made outside the ED. Patients with new NSCLC are often admitted from the ED for complications or to expedite workup, as earlier treatment correlates with better survival. However, hospital stays are resource-intensive and may not reduce time to treatment initiation (TTI). We compared characteristics and TTI for patients with an ED diagnosis of NSCLC who underwent inpatient versus outpatient workups. Methods: We identified 2007 patients at Kaiser Permanente Northern California, a large integrated health system, with new NSCLC diagnosed within 30 days of an ED visit from 1/1/2018 to 12/31/2021. We randomly sampled 600 for chart review and excluded patients who died within 30 days or lacked pathologic confirmation. Using Cox proportional hazards, we adjusted for age, sex, race, neighborhood deprivation, comorbidities, and stage to assess the impact of workup location on TTI for patients receiving cancer-directed treatment within 30 days. Results: Of 480 patients included, 286 (60%) underwent inpatient workups and 194 (40%) had outpatient workups. In unadjusted analyses, hospitalized patients were more likely to have stage IV disease (69% vs. 53%, p<0.001) and to receive treatment within 30 days (40% vs. 29%, p=0.005), but less likely to be treated at 1 year (74% vs. 85%, p=0.005). After adjustment, there was no difference in TTI between groups for all patients or patients with stage IV disease treated within 30 days. Conclusions: In our study, inpatient and outpatient workups for a new ED diagnosis of NSCLC resulted in similar adjusted TTI. These findings suggest that for patients who may receive early treatment and do not require hospitalization, outpatient NSCLC workup does not delay treatment initiation. Identifying patients suitable for outpatient workup could help preserve hospital resources without impeding timely treatment. Characteristics and outcomes by workup location after ED diagnosis of NSCLC. Univariate analysis Overall 1 n = 480 Hospital 1 n = 286 Outpatient 1 n = 194 p-value 2 Age, mean (SD) 71.6 (11.3) 71.2 (11.8) 72.2 (10.7) 0.2 Male sex 205 (43) 119 (42) 86 (44) 0.6 Neighborhood Deprivation Index (NPI): 4th quartile (most deprived) 115 (24) 67 (23) 48 (35) 0.7 Charlson Comorbidity Index (CCI) ≥5 137 (29) 90 (31) 47 (24) 0.09 Stage IV disease 299 (62) 196 (69) 103 (53) <0.001 Multivariate analysis Hazard Ratio 95% CI p-value 3 Any treatment at 30 days 0.90 0.72, 1.14 0.377 Any treatment at 30 days, stage IV only 0.89 0.66, 1.19 0.428 1 n (%), unless otherwise stated; 2 Chi-square test (categorical variables) or Wilcoxon rank-sum test (continuous variables), unadjusted; 3 Cox proportional hazard model comparing outpatient to hospital; adjusted for age, sex, race, NPI, CCI, and stage.

JCO Oncology PracticeVol. 21(10_suppl)
Kaiser Permanente (US), Kaiser Permanente San Francisco Medical Center (US), Kaiser Permanente Santa Clara Medical Center (US)
Openalex Percentile: Top 60%
Lung Cancer Treatments and Mutations
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.